cefepime hydrochloride

Drug ingredient

CAS 123171-59-5

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 123171-59-5
1 Cl⁻ · 1 H₂O · 1 HCl
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

14 FDA-registered drug labelers
ACS Dobfar S.p.A
Antibioticos do Brasil Ltda
Apotex Corp.
B. Braun Medical Inc.
Baxter Healthcare Company
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Orchid Pharma Ltd
Qilu Antibiotics Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Sagent Pharmaceuticals
SAMSON MEDICAL TECHNOLOGIES LLC
WG Critical Care, LLC

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • •Cefepime
  • •Cefepime Hydrochloride
  • •Cefepime Hydrochloride AND Dextrose
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Cefepime Hydrochloride Injection

    Shortage listed since February 10, 2026

See all current drug shortages

Chemical Identity

CAS123171-59-5
PubChem CID9571075
DTXSIDDTXSID7045603
FormulaC19H28Cl2N6O6S2
Mol. Weight571.5 g/mol
SMILESC[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]

Data Sources

Brief citations

cefepime hydrochloride (CAS 123171-59-5) https://chemicalindependence.com/chemical/123171-59-5/ PubChem: 9571075. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/9571075 FDA National Drug Code directory: CAS 123171-59-5. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 123171-59-5. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/